Argyle Capital Partners, LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 2079995
LOS ANGELES, CA
Position in TMO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$360,978
+$47,874 QoQ
Shares Held
720
+13.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#1,941
of 2,606 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Argyle Capital Partners, LLC holds $1,497,572 across 2 Diagnostics & Research names. TMO ranks #2 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
5,967 | $1,136,594 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
720 | $360,978 |
All Filings in TMO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $360,978 | 720 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $313,104 | 637 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $304,790 | 526 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $322,538 | 665 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $326,395 | 805 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||